Typical side effects include nausea, vomiting, diarrhea, and constipation, which are generally mild and tend to diminish after a few weeks of treatment
Proteccin renal con los agonistas del receptor del pptido similar al glucagn tipo 1 En los CVOT de los arGLP1 los resultados renales se preespecificaron como resultados secundarios clave en 4 estudios con liraglutida, semaglutida subcutnea, dulaglutida y efpeglenatida58,59,63,64, o se recogieron como parmetros de seguridad en otros estudios60
In some cases, supplements or dietary changes may be necessary
Supraclavicular lymphadenopathy is particularly concerning and requires urgent assessment regardless of duration, as outlined in NICE guideline NG12 for suspected cancer referral